PT Millennium Pharmacon International Tbk (SDPC.JK)
IDR 132.0
(0.76%)
IDR 132.0
(0.76%)
| Year | Eps | Eps Growth |
|---|---|---|
| 2023 | 25.97 IDR | 35.26% |
| 2022 | 19.20 IDR | 155.66% |
| 2021 | 7.51 IDR | 241.36% |
| 2020 | 2.20 IDR | -64.46% |
| 2019 | 6.19 IDR | -59.44% |
| 2018 | 15.26 IDR | -19.22% |
| 2017 | 18.89 IDR | 26.1% |
| 2016 | 14.98 IDR | -6.72% |
| 2015 | 16.06 IDR | 62.39% |
| 2014 | 9.89 IDR | -28.39% |
| 2013 | 13.81 IDR | 4.07% |
| 2012 | 13.27 IDR | 170.26% |
| 2011 | 4.91 IDR | 150.51% |
| 2010 | 1.96 IDR | -84.64% |
| 2009 | 12.76 IDR | 0.0% |
| Year | Eps | Eps Growth |
|---|---|---|
| 2024 Q3 | 4.03 IDR | -37.71% |
| 2024 Q2 | 6.47 IDR | 16.16% |
| 2024 Q1 | 5.57 IDR | 11.62% |
| 2023 Q1 | 4.59 IDR | 836.73% |
| 2023 FY | - IDR | 35.26% |
| 2023 Q4 | 4.99 IDR | 76.95% |
| 2023 Q3 | 2.82 IDR | -79.23% |
| 2023 Q2 | 13.58 IDR | 195.86% |
| 2022 Q3 | 7.79 IDR | 252.49% |
| 2022 Q4 | 0.49 IDR | -93.71% |
| 2022 Q1 | 8.72 IDR | 2591.43% |
| 2022 FY | - IDR | 155.66% |
| 2022 Q2 | 2.21 IDR | -74.66% |
| 2021 Q2 | 1.90 IDR | 171.43% |
| 2021 FY | - IDR | 241.36% |
| 2021 Q4 | -0.35 IDR | -106.65% |
| 2021 Q3 | 5.26 IDR | 176.84% |
| 2021 Q1 | 0.70 IDR | 198.59% |
| 2020 FY | - IDR | -64.46% |
| 2020 Q4 | -0.71 IDR | -545.45% |
| 2020 Q1 | 5.00 IDR | 615.46% |
| 2020 Q2 | -2.30 IDR | -146.0% |
| 2020 Q3 | -0.11 IDR | 95.22% |
| 2019 Q2 | 2.94 IDR | -2.0% |
| 2019 FY | - IDR | -59.44% |
| 2019 Q1 | 3.00 IDR | 69.49% |
| 2019 Q4 | -0.97 IDR | -194.17% |
| 2019 Q3 | 1.03 IDR | -64.97% |
| 2018 Q3 | 4.62 IDR | -48.49% |
| 2018 FY | - IDR | -19.22% |
| 2018 Q1 | 4.00 IDR | 56.25% |
| 2018 Q2 | 8.97 IDR | 124.25% |
| 2018 Q4 | 1.77 IDR | -61.69% |
| 2017 FY | - IDR | 26.1% |
| 2017 Q1 | 6.00 IDR | 141.94% |
| 2017 Q2 | 5.24 IDR | -12.67% |
| 2017 Q3 | 4.43 IDR | -15.46% |
| 2017 Q4 | 2.56 IDR | -42.21% |
| 2016 Q1 | 3.93 IDR | 18.73% |
| 2016 FY | - IDR | -6.72% |
| 2016 Q4 | 2.48 IDR | 1671.43% |
| 2016 Q3 | 0.14 IDR | -98.27% |
| 2016 Q2 | 8.09 IDR | 105.85% |
| 2015 Q2 | 5.72 IDR | 94.56% |
| 2015 Q1 | 2.94 IDR | -43.79% |
| 2015 FY | - IDR | 62.39% |
| 2015 Q4 | 3.31 IDR | -20.81% |
| 2015 Q3 | 4.18 IDR | -26.92% |
| 2014 Q1 | 2.94 IDR | -10.09% |
| 2014 FY | - IDR | -28.39% |
| 2014 Q3 | 1.04 IDR | 181.08% |
| 2014 Q2 | 0.37 IDR | -87.41% |
| 2014 Q4 | 5.23 IDR | 402.88% |
| 2013 Q3 | 4.14 IDR | 40.34% |
| 2013 Q2 | 2.95 IDR | -19.4% |
| 2013 Q4 | 3.27 IDR | -21.01% |
| 2013 FY | - IDR | 4.07% |
| 2013 Q1 | 3.66 IDR | -10.07% |
| 2012 FY | - IDR | 170.26% |
| 2012 Q3 | 2.66 IDR | 0.0% |
| 2012 Q4 | 4.07 IDR | 53.01% |
| 2011 FY | - IDR | 150.51% |
| 2010 FY | - IDR | -84.64% |
| 2009 FY | - IDR | 0.0% |
| Name | Eps | Eps Difference |
|---|---|---|
| PT Enseval Putera Megatrading Tbk. | 254.19 IDR | 89.783% |
| PT Itama Ranoraya Tbk | 3.37 IDR | -670.623% |
| PT Kimia Farma (Persero) Tbk | -267.48 IDR | 109.709% |
| PT Soho Global Health Tbk | 29.26 IDR | 11.244% |